{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Height&page=18", "query": { "intervention": "Height", "page": 18 }, "page_size": 10 }, "pagination": { "page": 18, "page_size": 10, "total_count": 464, "total_pages": 47, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Height&page=19&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Height&page=17&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T15:05:05.905Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00303602", "title": "Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia", "Schizoaffective Disorder", "Bipolar Disorder" ], "interventions": [ { "name": "Sublingual orally disintegrating olanzapine (SODO)", "type": "DRUG" }, { "name": "Oral olanzapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 149, "start_date": "2006-03", "completion_date": "2007-12", "has_results": true, "last_update_posted_date": "2009-06-10", "last_synced_at": "2026-10-23T15:05:05.905Z", "location_count": 7, "location_summary": "Escondido, California • Garden Grove, California • National City, California + 4 more", "locations": [ { "city": "Escondido", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "National City", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00303602" }, { "nct_id": "NCT04219007", "title": "Vosoritide for Selected Genetic Causes of Short Stature", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Short Stature" ], "interventions": [ { "name": "Vosoritide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Andrew Dauber", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "10 Years", "sex": "ALL", "summary": "3 Years to 10 Years" }, "enrollment_count": 56, "start_date": "2020-08-04", "completion_date": "2035-06-01", "has_results": false, "last_update_posted_date": "2026-03-18", "last_synced_at": "2026-10-23T15:05:05.905Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04219007" }, { "nct_id": "NCT04138875", "title": "A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "PTLD", "Lymphoid Tumor", "Hematopoietic/Lymphoid Cancer", "Plasmacytic Hyperplasia PTLD", "Infectious Mononucleosis", "Florid Follicular Hyperplasia PTLD", "Polymorphic PTLD", "Monomorphic PTLD", "Classical Hodgkin Lymphoma Type PTLD" ], "interventions": [ { "name": "Rituximab", "type": "DRUG" }, { "name": "Brentuximab Vedotin", "type": "DRUG" }, { "name": "Bendamustine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 0, "start_date": "2022-01", "completion_date": "2023-12", "has_results": false, "last_update_posted_date": "2022-06-23", "last_synced_at": "2026-10-23T15:05:05.905Z", "location_count": 2, "location_summary": "New Haven, Connecticut • Rochester, Minnesota", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04138875" }, { "nct_id": "NCT00611728", "title": "Ph I SU011248 + Irinotecan in Treatment of Pts w MG", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Glioblastoma" ], "interventions": [ { "name": "SU011248 & Irinotecan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2008-03", "completion_date": "2010-09", "has_results": false, "last_update_posted_date": "2014-07-21", "last_synced_at": "2026-10-23T15:05:05.905Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00611728" }, { "nct_id": "NCT07465172", "title": "GDF-15 and Its Relationship With Treatment-related ADverse Events in Breast Cancer", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Blood collection for GDF-15", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Breast Cancer Trials, Australia and New Zealand", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2026-10", "completion_date": "2028-10", "has_results": false, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-10-23T15:05:05.905Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07465172" }, { "nct_id": "NCT01890694", "title": "Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hyponatremia" ], "interventions": [ { "name": "Tolvaptan", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Hepatic Encephalopathy Assessment", "type": "BEHAVIORAL" }, { "name": "Quality of Life Assessment", "type": "BEHAVIORAL" }, { "name": "Vital signs", "type": "BIOLOGICAL" }, { "name": "Blood laboratory tests", "type": "BIOLOGICAL" }, { "name": "Ascites Evaluation", "type": "PROCEDURE" }, { "name": "Edema", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "BEHAVIORAL", "BIOLOGICAL", "PROCEDURE" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2012-03", "completion_date": "2015-03", "has_results": true, "last_update_posted_date": "2017-12-11", "last_synced_at": "2026-10-23T15:05:05.905Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01890694" }, { "nct_id": "NCT06397677", "title": "Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Rheumatoid Arthritis", "Interstitial Lung Disease" ], "interventions": [ { "name": "Research Testing Performed (Laboratory)", "type": "GENETIC" }, { "name": "Information Collected as Standard of Care", "type": "DIAGNOSTIC_TEST" }, { "name": "Research Testing Performed", "type": "OTHER" } ], "intervention_types": [ "GENETIC", "DIAGNOSTIC_TEST", "OTHER" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 450, "start_date": "2024-01-22", "completion_date": "2034-01", "has_results": false, "last_update_posted_date": "2024-05-03", "last_synced_at": "2026-10-23T15:05:05.905Z", "location_count": 4, "location_summary": "San Francisco, California • Aurora, Colorado • Kansas City, Kansas + 1 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT06397677" }, { "nct_id": "NCT05809557", "title": "EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Oncology", "Chemotherapeutic Toxicity", "Metastatic Solid Tumor" ], "interventions": [ { "name": "Chemotherapy toxicity tool", "type": "OTHER" }, { "name": "Oncology Consultation", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 34, "start_date": "2023-01-09", "completion_date": "2024-01-09", "has_results": false, "last_update_posted_date": "2024-02-28", "last_synced_at": "2026-10-23T15:05:05.905Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05809557" }, { "nct_id": "NCT04575090", "title": "7 Tesla MRI Study in Patients With Statin Related Muscle Complaints", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Statin-related Muscle Pain", "Muscle Aches", "Muscle Weakness", "Muscle Cramp", "Muscle Stiffness" ], "interventions": [ { "name": "Simvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 8, "start_date": "2016-03-05", "completion_date": "2021-06-23", "has_results": true, "last_update_posted_date": "2022-10-31", "last_synced_at": "2026-10-23T15:05:05.905Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04575090" }, { "nct_id": "NCT04496830", "title": "SPINCOMS Biomarker Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Multiple Sclerosis" ], "interventions": [], "intervention_types": [], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 161, "start_date": "2020-06-15", "completion_date": "2023-11-24", "has_results": false, "last_update_posted_date": "2025-09-11", "last_synced_at": "2026-10-23T15:05:05.905Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT04496830" } ] }